Vimarsana
Biggest News Aggregation in the World

Page 4 - Functional Class News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Functional Class. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Functional Class Today - Breaking & Trending Today

Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update

SAN DIEGO--(BUSINESS WIRE)--Nov 9, 2023--

Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update - Vimarsana News

Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Oral arguments in appeal of ‘793 PTAB decision set for December 4, 2023PDUFA goal date to add PH-ILD indication to YUTREPIA label is January 24, 2024Hired sales force in preparation of potential...

Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves - Vimarsana News

Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves

New data presented at Transcatheter Cardiovascular Therapeutics (TCT) 2023 from the TRILUMINATE pivotal trial confirm safety, effectiveness and improvements in quality of life when treating tricuspid regurgitation (a leaky valve) with TriClip, an investigational device in the US 

Abbott reports positive TriClip, MitraClip data - Vimarsana News

Abbott reports positive TriClip, MitraClip data

Abbott (NYSE: ABT) announced positive data for two of its minimally invasive heart devices for treating mitral and tricuspid valve disease.

Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves - Vimarsana News

Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves

New data presented at Transcatheter Cardiovascular Therapeutics 2023 from the TRILUMINATE™ pivotal trial confirm safety, effectiveness and improvements in quality of life when treating tricuspid...